Springer Nature Aktie 41578404 / DE000SPG1003
Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
---|---|---|---|---|---|---|
Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
Orderbuch | Analysen | |||||
Historisch |
12.08.2025 18:52:34
|
EQS-Adhoc: SPRINGER NATURE AG & Co. KGaA: Springer Nature raises guidance for the full year 2025
EQS-Ad-hoc: Springer Nature AG & Co. KGaA / Key word(s): Change in Forecast Springer Nature AG & Co. KGaA (“Springer Nature”) today raises its guidance for the 2025 fiscal year, reflecting its strong performance year to date. In the first six months of 2025, revenue increased to €926 million and adjusted operating profit to €241 million, representing underlying growth of 6% and 10% respectively.
Given the continued positive development across its business, the company now expects underlying1 Group revenue to be in the range of €1,930 million to €1,960 million (previously: in the upper half of the range of €1,885 million to €1,935 million) and underlying1 adjusted operating profit (AOP) to be in the range of €540 million to €560 million (previously: in the upper half of the range of €523 million to €546 million). The upward revision is driven by the strong development in the Research segment, where nearly all 2025 contract renewals have been completed and continued high submission volumes, particularly in Full Open Access journals, are driving above-market publication growth. The Health and Education segments continue to perform in line with their respective markets, and supporting the overall Group performance. Springer Nature will release its results for the first half-year 2025 on August 13, 2025. 1 At 2025 constant FX rates and excluding scope effects; 1 EUR = 1.082 USD = 0.847 GBP = 163.8 JPY --------------------------------------------- Contact: Thomas Geisselhart EVP Corporate Finance, Group Treasury & Investor Relations tel +49 30 82787 5111 thomas.geisselhart@springernature.com --------------------------------------------- Disclaimer Forward-looking statements This announcement contains forward-looking statements. These forward-looking statements can be identified by the use of forward looking terminology, including the terms "plans," "targets," "aims," "continues," "believes," "estimates," "anticipates," "expects," "intends," "may," "will" or "should" or, in each case, their negative, or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. The Company does not take any responsibility to update, review or revise any forward-looking statement contained in this announcement whether as a result of new information, future developments or otherwise, unless it is required to do so under mandatory law. Use of alternative performance measures This release includes certain financial measures not presented in accordance with IFRS, which may exclude items that are significant in understanding and assessing the Company’s financial results. These measures should not be considered in isolation or as an alternative to measures of profitability, liquidity or performance under IFRS. Regarding the definition of the alternative performance measure adjusted operating profit and underlying change, the Company refers to the corresponding definition on page 39 of the 2024 Annual Report under the headings “Key performance indicators” and “Other financial performance indicators”, which is available on the Company’s investor relations website. End of Inside Information
12-Aug-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | Springer Nature AG & Co. KGaA |
Heidelberger Platz 3 | |
14197 Berlin | |
Germany | |
Phone: | +49 (0)30 - 82787 - 0 |
E-mail: | ir@springernature.com |
Internet: | www.springernature.com |
ISIN: | DE000SPG1003 |
WKN: | SPG100 |
Indices: | SDAX |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Munich, Stuttgart, Tradegate Exchange; Vienna Stock Exchange (Vienna MTF) |
EQS News ID: | 2183020 |
End of Announcement | EQS News Service |
|
2183020 12-Aug-2025 CET/CEST
Nachrichten zu Springer Nature
03.09.25 |
Pluszeichen in Frankfurt: SDAX verbucht nachmittags Zuschläge (finanzen.ch) | |
31.08.25 |
August 2025: So schätzen Experten die Springer Nature-Aktie ein (finanzen.net) | |
29.08.25 |
Freitagshandel in Frankfurt: SDAX legt zum Start des Freitagshandels zu (finanzen.ch) | |
26.08.25 |
XETRA-Handel So steht der SDAX am Nachmittag (finanzen.ch) | |
25.08.25 |
SDAX-Handel aktuell: SDAX sackt zum Start ab (finanzen.ch) | |
21.08.25 |
Optimismus in Frankfurt: SDAX bewegt sich zum Handelsstart im Plus (finanzen.ch) | |
19.08.25 |
EQS-DD: Springer Nature AG & Co. KGaA: Rachel Jacobs, sell (EQS Group) | |
19.08.25 |
EQS-DD: Springer Nature AG & Co. KGaA: Rachel Jacobs, Verkauf (EQS Group) |
Analysen zu Springer Nature
15.08.25 | Springer Nature Buy | Goldman Sachs Group Inc. | |
13.08.25 | Springer Nature Overweight | JP Morgan Chase & Co. | |
31.07.25 | Springer Nature Buy | Deutsche Bank AG | |
04.07.25 | Springer Nature Overweight | Barclays Capital | |
01.07.25 | Springer Nature Overweight | JP Morgan Chase & Co. |
KI Aktien – Gewinner der Digitalisierung – Wall Street Live mit Tim Schäfer
In dieser Folge sprechen wir mit Tim Schäfer live aus New York über den aktuellen Stand der KI-Aktien. Sind die Kurse von Nvidia, Microsoft, Meta, Amazon, Alphabet und Apple noch gerechtfertigt – oder stehen wir kurz vor einer Spekulationsblase?
📈 Tim analysiert die Zahlen, Investitionen und Bewertungen der grossen Tech-Konzerne und zeigt, wie viel Kapital derzeit in KI-Infrastruktur fliesst. Zudem diskutieren wir, welche Randbereiche vom KI-Boom profitieren könnten – etwa Rechenzentren, Stromversorger oder Hardwarehersteller.
Themen im Video:
🔹Die „Magnificent 7“ im Check: Meta, Microsoft, Nvidia, Amazon, Alphabet, Apple
🔹Investitionen in KI: 71 Mrd. bei Meta, 120 Mrd. bei Microsoft
🔹Nvidia: Marktführer, aber extrem teuer
🔹Apple: Aufholjagd oder zu spät dran?
🔹Gefahr einer KI-Blase?
🔹Welche Alternativen bieten sich für Langfristinvestoren?
🔹Rechenzentren, Energieanbieter & Zulieferer im Fokus
🔹Wie Tim mit Rücksetzern und Seitwärtsphasen umgeht
🔹Erste Anzeichen für eine neue Superintelligenz?
👉🏽 https://bxplus.ch/wall-street-live-mit-tim-schaefer/
Inside Trading & Investment
Mini-Futures auf SMI
Inside Fonds
Meistgelesene Nachrichten
Top-Rankings
Börse aktuell - Live Ticker
Nach US-Arbeitsmarktzahlen: SMI geht etwas leichter ins Wochenende -- DAX letztlich in Rot -- Gewinnmitnahmen an den US-Börsen -- Märkte in Asien schliessen mit AufschlägenDer heimische Leitindex präsentierte sich am Freitag etwas schwächer. Am deutschen Aktienmarkt ging es abwärts. Die US-Börsen gaben nach neuen Rekorden nach. In Fernost dominierten die Käufer.
finanzen.net News
Datum | Titel |
---|---|
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
|
{{ARTIKEL.NEWS.BODY.TITEL}} |